Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
Tóm tắt
To perform a meta-analysis to compare 18FDG PET, CT, MRI and bone scintigraphy (BS) for the diagnosis of bone metastases. Databases including MEDLINE and EMBASE were searched for relevant original articles published from January 1995 to January 2010. Software was used to obtain pooled estimates of sensitivity, specificity and summary receiver operating characteristic curves (SROC). 67 articles consisting of 145 studies fulfilled all inclusion criteria. On per-patient basis, the pooled sensitivity estimates for PET, CT, MRI and BS were 89.7%, 72.9%, 90.6% and 86.0% respectively. PET=MRI>BS>CT. (“=”indicated no significant difference, P > 0.05; “>” indicated significantly higher, P < 0.05). The pooled specificity estimates for PET, CT, MRI and BS were 96.8%, 94.8%, 95.4% and 81.4% respectively. PET = CT = MRI>BS. On per-lesion basis, the pooled sensitivity estimates for PET, CT, MRI and BS were 86.9%, 77.1%, 90.4% and 75.1% respectively. PET = MRI>BS>CT. The pooled specificity estimates for PET, CT, MRI and BS were 97.0%, 83.2%, 96.0% and 93.6% respectively. PET>MRI>BS>CT. PET and MRI were found to be comparable and both significantly more accurate than CT and BS for the diagnosis of bone metastases.
Tài liệu tham khảo
Even-Sapir E (2005) Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 46:1356–1367
Padhani A, Husband J (1998) Bone metastases. In: Husband JES, Reznek RH (eds) Imaging in oncology. Isis Medical Media Ltd, Oxford, pp 765–787
Rubens RD (1998) Bone metastases: the clinical problem. Eur J Cancer 34:210–213
Rybak LD, Rosenthal DI (2001) Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 45:53–64
Hamaoka T, Madewell JE, Podoloff DA et al (2004) Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol 22:2942–2953
Roodman GD (2001) Biology of osteoclast activation in cancer. J Clin Oncol 19:3562–3571
Van Houwelingen HC, Zwinderman KH, Stijnen T (1993) A bivariate approach to meta-analysis. Stat Med 12:2273–2284
Van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21:589–624
Deville WL, Bezemer PD, Bouter LM (2000) Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy. J Clin Epidemiol 53:65–69
Berlin JA (1997) Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 350:185–186
Whiting P, Rutjes AW, Reitsma JB et al (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Meth 3:25
Moses LE, Shapiro D, Littenberg B (1993) Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12:1293–1316
Zamora J, Abraira V, Muriel A et al (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Meth 6:31
Eustace S, Tello R, Carey J et al (1997) A comparison of whole-body turbostir MR imaging and planar 99 m Tc-Methylene Diphosphonate Scintigraphy in the examination of patients with suspected skeletal metastasis. Am J Roentgenol 169:1655–1661
Bury T, Barreto A, Daenen F et al (1998) Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25:1244–1247
Gibril F, Doppman JL, Reynolds JC et al (1998) Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management. J Clin Oncol 16:1040–1053
Schirrmeister H, Guhlmann A, Elsner K et al (1999) Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18 F-PET. J Nucl Med 40:1623–1629
Yip CH, Paramsothy M (1999) Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer. Breast 8:267–269
Lebtahi R, Cadiot G, Delahaye N et al (1999) Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 40:1602–1608
Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413
Schirrmeister H, Guhlmann A, Kotzerke J et al (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17:2381–2389
Earnest F, Ryu JH, Miller GM et al (1999) Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection - pilot study. Radiology 211:137–145
Layer G, Steudel A, Schuller H et al (1999) Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma. Cancer 85:1004–1009
Schirrmeister H, Glatting G, Hetzel J et al (2001) Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18 F-Labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 42:1800–1804
Koga S, Tsuda S, Nishikido M et al (2001) The diagnostic value of bone scan in patents with renal cell carcinoma. J Urology 166:2126–2128
Altehoefer C, Ghanem N, Hogerle S et al (2001) Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer. Eur J Radiol 40:16–23
Ohta M, Tokuda Y, Suzuki Y et al (2001) Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun 22:875–879
Savelli G, Maffioli L, Maccauro M et al (2001) Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med 45:27–37
Buchmann I, Reinhardt M, Elsner K et al (2001) 2-(Fluorine-18)Fluoro-2-Deoxy-D-Glucose positron emission tomography in the detection and staging of malignant lymphoma: a bicenter trial. Cancer 91:889–899
Wu HC, Yen RF, Shen YY et al (2002) Comparing whole body 18 F-2-deoxyglucose positron emission tomography and technetium-99 m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas – a preliminary report. J Cancer Res Clin Oncol 128:503–506
Ghanem N, Altehoefer C, Hogerle S et al (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton. Eur J Radiol 43:256–261
Yang SN, Liang JA, Lin FJ et al (2002) Comparing whole body 18 F-2-deoxyglucose positron emission tomography and technetium-99 m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol 128:325–328
Hsia TC, Shen YY, Yen RF et al (2002) Comparing whole body 18 F-2-deoxyglucose positron emission tomography and technetium-99 m methylene diphosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 49:267–271
Prior JO, Barghouth G, Delaloye JF et al (2003) The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer. Nucl Med Commun 24:29–36
Zhang C, Zhou Q, Chen YH et al (2003) Comparison of 18 F-FDG PET with 99mTc-MDP bone scan in detection of bone metastases. Chin J Nucl Med 23:201–203
Lee KH, Park JM, Yoon JK et al (2003) Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE. Hepato-Gastroenterology 50:1983–1986
Han LJ, Qu WY, He J et al (2003) Comparison of the clinical values of 18 F-FDG hPET/CT and 99mTc-MDP bone scan in detection of bone metastases. Chin J Nucl Med 23:204–206
Nakamoto YJ, Osman M, Wahl RL (2003) Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Clin Nucl Med 28:302–307
Bossche BVD, Dhaeninck E, Winter FD et al (2004) 99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer. Nucl Med Commun 25:787–792
Schirrmeister H, Arslandemir C, Glatting G et al (2004) Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Eur J Nucl Med Mol Imag 31:964–968
Cheran SK, Herndon JE 2nd, Patz EF Jr (2004) Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44:317–325
Engelhard K, Hollenbach HP, Wohlfart K et al (2004) Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 14:99–105
Lauenstein TC, Goehde SC, Herborn CU et al (2004) Whole-body MR imaging: evaluation of patients for metastases. Radiology 233:139–148
Abe K, Sasaki M, Kuwabara Y et al (2005) Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 19:573–579
Nakai T, Okuyama C, Kubota T et al (2005) Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imag 32:1253–1258
Kato H, Miyazaki T, Nakajima M et al (2005) Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res 25:4439–4444
Uematsu T, Yuen S, Yukisawa S et al (2004) Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol 184:1266–1273
Fujimoto R, Higashi T, Nakamoto Y et al (2006) Diagnostic accuracy of bone metastases detection in cancer patients: Comparison between bone scintigraphy and whole-body FDG-PET. Ann Nucl Med 20:399–408
Gao Y, Fang J, Liu XY et al (2006) Diagnostic value of nuclide bone imaging for bone metastasis from lung cancer and clinic analysis. Chin J Lung Canc 9:357–361
Groves AM, Beadsmoore CJ, Cheow HK et al (2006) Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient. Eur Radiol 16:1066–1073
Sadik M, Jakobsson D, Olofsson F et al (2006) A new computer-based decision-support system for the interpretation of bone scans. Nucl Med Commun 27:417–423
Liu FY, Chang JT, Wang HM et al (2006) [18 F]Fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol 24:599–604
Sapir EE, Metser U, Mishani E et al (2006) The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and Multi-Field-of-View SPECT, 18 F-Fluoride PET, and 18 F-Fluoride PET/CT. J Nucl Med 47:287–297
Aslan S, Cetin B, Akinci M et al (2006) Computed tomography in detecting bone metastases of breast carcinoma. Is it better than plain x-ray? Saudi Med J 27:1326–1328
Hur J, Yoon CS, Ryu YH et al (2007) Accuracy of fluorodeoxyglucose positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy. J Comput Assist Tomogr 31:812–819
Phan HT, Jager PL, Plukker JT et al (2007) Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18 F-FDG PET? Nucl Med Commun 28:597–602
Strobel K, Burger C, Brukhardt S et al (2007) Characterization of focal bone lesions in the axial skeleton: lesions in the axial skeleton: scintigraphy compared with SPECT and SPECT fused with CT. AJR Am J Roentgenol 188:467–474
Ito S, Kato K, Ikeda M et al (2007) Comparison of 18 F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer. J Nucl Med 48:889–895
Schmidt GP, Schoenberg SO, Schmid R et al (2007) Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 17:939–949
Taira A, Herfkens RJ, Gambhir SS et al (2007) Detection of bone metastases: assessment of integrated FDG PET/CT Imaging. Radiology 243:204–211
Pfannenberg C, Aschoff P, Schanz S et al (2007) Prospective comparison of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43:557–564
Lecouvet FE, Geukens D, Stainier A et al (2007) Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol 25:3281–3287
Xu X, Ma L, Zhang JS et al (2008) Feasibility of whole body diffusion weighted imaging in detecting bone metastasis on 3.0 T MR scanner. Chin Med Sci J 23:151–157
Sadik M, Suurkula M, Hoglund P et al (2008) Quality of planar whole-body bone scan interpretations—a nationwide survey. Eur J Nucl Med Mol Imag 35:1464–1472
Kim MR, Roh JL, Kin JS et al (2008) 18 F-Fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract. Oral Oncol 44:148–152
Bistow AR, Agrawal A, Evans AJ et al (2008) Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study. Breast 17:100–105
Wu SQ, Liu JJ, Song SS et al (2008) Comparison of the value of 18 F-FDG PET and 99mTc-MDP bone scan in the detection of bone metastases. Radiol Pract 23:1273–1277
Song JW, Oh YM, Shim TS et al (2009) Efficacy comparison between 18 F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Lung Cancer 65:333–338
Takenaka D, Ohno Y, Matsumoto K et al (2009) Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR Imaging without and with DWI, whole-Body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging 30:298–308
Venkitaraman R, Cook G, Dearnaley D et al (2009) Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J Med Imaging Radiat Oncol 53:241–247
Min JW, Um SW, Yi JJ et al (2009) The Role of whole-Body FDG PET/CT, Tc 99 m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer. J Kor Med Sci 24:275–280
Costo S, Halley A, Bergot E et al (2009) Usefulness of 99mTc-depreotide scintigraphy for the diagnosis of bone metastases in non-small cell lung cancer stage III–IV. Med Nucl 33:201–210
Kruger S, Buck AK, Mottaghy FM et al (2009) Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18 F-fluoride PET or 18 F-FDG PET/CT. Eur J Nucl Med Mol Imag 36:1807–1812
Sohaib SA, Cook G, Allen SD et al (2009) Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer. Br J Radiol 82:632–639
Xu WN, Xin J, Yu SP et al (2009) Comparison of 18 F-FDG PET-CT and 99mTc-MDP bone scintigraphy in detection of bone metastases. J Chin Clin Med Imaging 20:323–327
Liu NB, Ma L, Zhou W et al (2010) Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT. Eur J Radiol 74:231–235
Liu FY, Yen TC, Chen MY et al (2009) Detection of hematogenous bone metastasis in cervical cancer: 18 F-Fluorodeoxyglucose–positron emission tomography versus computed tomography and magnetic resonance imaging. Cancer 115:5470–5480
Heusner T, Golitz P, Hamami M et al (2011) “One-stop-shop” staging: Should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Eur J Radiol 78:430–435
Putzer D, Gabriel M, Henninger B et al (2009) Bone metastases in patients with neuroendocrine tumor:68 Ga-DOTA-Tyr3-Octreotide PET in comparison to CT and bone scintigraphy. J Nucl Med 50:1214–1221
Zhao Z, Li L, Li FL et al (2010) Single photon emission computed tomography/spiral computed tomography fusion imaging for the diagnosis of bone metastasis in patients with known cancer. Skeletal Radiol 39:147–153
Lijmer JG, Mol BW, Heisterkamp S et al (1999) Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282:1061–1066
Rutter CM, Gatsonis CA (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20:2865–2884
Pham B, Platt R, McAuley L et al (2001) Is there a “best” way to detect and minimize publication bias? an empirical evaluation. Eval Health Prof 24:109–125
Bossuyt PM, Reitsma JB, Bruns DE et al (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Radiology 226:24–28
Fay MP, Graubard BI, Freedman LS et al (1998) Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics 54:195–208
Bipat S, van Leeuwen MS, Comans EF et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis – meta-analysis. Radiology 237:123–131
Tryciecky EW, Gottschalk A, Ludema K (1997) Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model. Semin Nucl Med 27:142–151
Deeks J (2001) Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323:157–162
Cook GJ, Houston S, Rubens R et al (1998) Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375–3379
Muindi J, Coombes RC, Golding S et al (1983) The role of computed tomography in the detection of bone metastases in breast cancer patients. Br J Radiol 56:233–236
Karnholz R, Sze G (1991) Current imaging in spinal metastatic disease. Semin Oncol 18:158–169
Vogler JB, Murphy WA (1988) Bone marrow imaging. Radiology 168:679–693
Blake GM, Park-Holohan SJ, Cook GJ et al (2001) Quantitative studies of bone with the use of 18 F-fluoride and 99mTc-methylene diphosphonate. Semin Nucl Med 31:28–49
Cook GJ, Fogelman I (2000) The role of positron emission tomography in the management of bone metastases. Cancer 88:2927–2933
Loeffler RK, DiSimone RN, Howland WJ (1975) Limitations of bone scanning in clinical oncology. JAMA 234:1228–1232
Roland J, van den Weygaert D, Krug B et al (1995) Metastases seen on SPECT imaging despite a normal planar bone scan. Clin Nucl Med 20:1052–1054
Sedonja I, Budihna NV (1999) The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine. Clin Nucl Med 24:407–413